yearly < years < yearsrid

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by years

Number of relevant bibliographic references: 388.
[20-40] [0 - 20][0 - 50][40-60]

Ident.	Authors (with country if any)	Title
000497 (2019)	Phyo Wai Minn ; Hemant Deepak Shewade [Inde] ; Nang Thu Thu Kyaw ; Khaing Hnin Phyo ; Nay Yi Yi Linn ; Myat Sandi Min ; Yan Naing Aung ; Zaw Toe Myint ; Aung Thi	Quality of Malaria Treatment Provided under ‘Better Health Together’ Project in Ethnic Communities of Myanmar: How Are We Performing?
000498 (2019)	Solomon Opoku [Ghana] ; Isaac Nyanor [Ghana]	Qualitative and Quantitative Microbiological Studies of Paediatric Artemether-Lumefantrine Dry Powders and Paracetamol Syrups Obtained from Selected Drug Stores in Accra, Ghana
000512 (2019)	Mohamed Abdelaleem [Égypte] ; Hossam Ezzat [Égypte] ; Muhammed Osama [Égypte] ; Adel Megahed [Égypte] ; Waleed Alaa [Égypte] ; Ahmed Gaber [Égypte] ; Ayman Shafei [Égypte] ; Alaa Refaat [Égypte, Japon]	Prospects for repurposing CNS drugs for cancer treatment
000525 (2019)	Emiliano Panieri [Italie] ; Luciano Saso [Italie]	Potential Applications of NRF2 Inhibitors in Cancer Therapy
000528 (2019)	Chiara Focaccetti ; Valerio Izzi ; Monica Benvenuto ; Sara Fazi ; Sara Ciuffa ; Maria Gabriella Giganti ; Vito Potenza ; Vittorio Manzari ; Andrea Modesti ; Roberto Bei	Polyphenols as Immunomodulatory Compounds in the Tumor Microenvironment: Friends or Foes?
000545 (2019)	Denis Choquette [Canada] ; Louis Bessette [Canada] ; Evo Alemao [États-Unis] ; Boulos Haraoui [Canada] ; Roelien Postema [Royaume-Uni] ; Jean-Pierre Raynauld [Canada] ; Louis Coupal [Canada]	Persistence rates of abatacept and TNF inhibitors used as first or second biologic DMARDs in the treatment of rheumatoid arthritis: 9 years of experience from the Rhumadata® clinical database and registry
000603 (2019)	Magdalena Bamburowicz-Klimkowska [Pologne] ; Magdalena Poplawska [Pologne] ; Ireneusz P. Grudzinski [Pologne]	Nanocomposites as biomolecules delivery agents in nanomedicine
000629 (2019)	Zheng Li ; Shuhao Liu ; Tengfei Fu ; Yi Peng ; Jian Zhang	Microtubule destabilization caused by silicate via HDAC6 activation contributes to autophagic dysfunction in bone mesenchymal stem cells
000647 (2019)	Christiana M. Neophytou ; Theodora-Christina Kyriakou ; Panagiotis Papageorgis	Mechanisms of Metastatic Tumor Dormancy and Implications for Cancer Therapy
000750 (2019)	Alfonso Serrano-Del Valle ; Alberto Anel ; Javier Naval ; Isabel Marzo	Immunogenic Cell Death and Immunotherapy of Multiple Myeloma
000778 (2019)	João M. A. Delou ; Alana S. O. Souza ; Leonel C. M. Souza ; Helena L. Borges	Highlights in Resistance Mechanism Pathways for Combination Therapy
000845 (2019)	Kevin Zarrabi [États-Unis] ; Azzam Paroya [États-Unis] ; Shenhong Wu [États-Unis]	Emerging therapeutic agents for genitourinary cancers
000853 (2019)	John Tesser [États-Unis] ; Shelly Kafka [États-Unis] ; Raphael J. Dehoratius [États-Unis] ; Stephen Xu [États-Unis] ; Elizabeth C. Hsia [États-Unis] ; Anthony Turkiewicz [États-Unis]	Efficacy and safety of intravenous golimumab plus methotrexate in patients with rheumatoid arthritis aged < 65 years and those ≥ 65 years of age
000884 (2019)	Anna Stainer [Royaume-Uni] ; Alex Rice [Royaume-Uni] ; Anand Devaraj [Royaume-Uni] ; Joseph Luke Barnett [Royaume-Uni] ; Jacqueline Donovan [Royaume-Uni] ; Maria Kokosi [Royaume-Uni] ; Andrew Gordon Nicholson [Royaume-Uni] ; Tom Cairns [Royaume-Uni] ; Athol Umfrey Wells [Royaume-Uni] ; Elisabetta Augusta Renzoni [Royaume-Uni]	Diffuse alveolar haemorrhage associated with subsequent development of ANCA positivity and emphysema in three young adults
000890 (2019)	Lawrence H. Cheung [États-Unis] ; Yunli Zhao [États-Unis] ; Ana Alvarez-Cienfuegos [États-Unis] ; Khalid A. Mohamedali [États-Unis] ; Yu J. Cao [États-Unis, République populaire de Chine] ; Walter N. Hittelman [États-Unis] ; Michael G. Rosenblum [États-Unis]	Development of a human immuno-oncology therapeutic agent targeting HER2: targeted delivery of granzyme B
000900 (2019)	Ignasi Figueras-Nart [Espagne] ; José M. Mascar [Espagne] ; Xavier Solanich [Espagne] ; José Hernández-Rodríguez [Espagne]	Dermatologic and Dermatopathologic Features of Monogenic Autoinflammatory Diseases
000990 (2019)	Volker Schirrmacher ; Stefaan Van Gool ; Wilfried Stuecker	Breaking Therapy Resistance: An Update on Oncolytic Newcastle Disease Virus for Improvements of Cancer Therapy
000994 (2019)	Ajay P. Nayak [États-Unis] ; Dominic Villalba [États-Unis] ; Deepak A. Deshpande [États-Unis]	Bitter Taste Receptors: an Answer to Comprehensive Asthma Control?
000A35 (2019)	Alyssa La Belle Flynn [États-Unis] ; William P. Schiemann [États-Unis]	Autophagy in breast cancer metastatic dormancy: Tumor suppressing or tumor promoting functions?
000A67 (2019)	Hui Song ; Li-Ping Zhong ; Jian He ; Yong Huang ; Yong-Xiang Zhao	Application of Newcastle disease virus in the treatment of colorectal cancer
000B42 (2019)	Lucie Cechakova ; Martin Ondrej ; Vojtech Pavlik [République tchèque] ; Petr Jost ; Dana Cizkova ; Ales Bezrouk ; Jaroslav Pejchal ; Ravi K. Amaravadi ; Jeffrey D. Winkler ; Ales Tichy	A Potent Autophagy Inhibitor (Lys05) Enhances the Impact of Ionizing Radiation on Human Lung Cancer Cells H1299

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "years" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "years" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    years
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021